Cellnovo Targets 2018 Launch Of Insulin Micropump With Artificial Pancreas Tech

Cellnovo has signed a commercial license agreement with digital health firm TypeZero to integrate its artificial pancreas software technology into Cellnovo’s digitally connected insulin patch pump. The integrated product is expected to launch in 2018.